Serial entrepreneur Gerry Brandon has signed a €3 million joint venture agreement with a view to developing biodegradable human implants and bringing them to market.
The consortium is made up of three companies: Brandon's Cellulac Ltd, clinical research organisation Venn Life Sciences and Mayo-based medical device company Biopharmed West.
A new arm of Venn Life Sciences with a focus on co-development opportunities, InnoVenn, is the division involved in the venture.
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team